🔓 Unlock the full profile of David Hung (Nuvation Bio), including verified contact details, financial insights, and professional associations.
See David Hung Full ProfileBelow are the ✅ Verified Contact Details to help you connect directly:
Email: dav*****@nuv******.com
Mobile: 97839*****
Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)
Key Insights You Should Know About This Individual
- David Hung is the Founder, President, and CEO of Nuvation Bio, a biotechnology company established in July 2019, situated in New York, New York.
- Nuvation Bio focuses on developing a new generation of cancer therapeutics, with emphasis on innovating treatments that are more effective and have fewer side effects.
- The company was founded with the aim to harness cutting-edge technology and scientific research to address significant unmet medical needs in the oncology sector.
- Under David Hung's leadership, Nuvation Bio has experienced significant headcount growth, with a notable increase of 164% over six months and 115% over the past year.
- Nuvation Bio is publicly traded on NASDAQ under the symbol NUVB, showcasing its commitment to transparency and growth in the competitive biotech market.
- Prior to Nuvation Bio, David Hung founded and served as President and CEO of Medivation, a biopharmaceutical company that developed innovative therapies, which was later acquired by Pfizer for $14 billion in 2016.
- David Hung has substantial experience in the biotechnology industry, having held significant positions at Pro•Duct Health, Inc. and Chiron Corporation, where contributions included vice president roles overseeing lead discovery and development projects.
- Nuvation Bio operates from a strategic base in New York, enabling access to a vibrant ecosystem of biotech development and investment opportunities.